BMD-003 (Suzhou BodMed)

N/A

Report date: 2026/04/24 20:01:59
First In Class

Base Information

Drug NameBMD-003 (Suzhou BodMed)
Drug Alias NameBMD-003
ClassificationCell and gene therapy > Gene therapy > mRNA
Mechanisms of ActionCFTR gene transference
TargetsCystic fibrosis transmembrane conductance regulator
Therapy Area/IndicationsCystic Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSuzhou BodMed Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsCystic Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A